țineo așa nimic expirare c myc gene Afirma Înainte organic
IJMS | Free Full-Text | Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells - Lorena A. Kallal, Anna Waszkiewicz, Jon-Paul Jaworski, Anthony Della Pietra, Tom Berrodin, Pat Brady, Anthony J. Jurewicz, Xin
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies | Journal of Hematology & Oncology | Full Text
researchopenworld.com
c-Myc A Biological Paradox - ppt video online download
Myc Oncogene (Molecular Biology)
IJMS | Free Full-Text | Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
Myc Mutations and Cancer
Figure 1 from Myc oncogenes: the enigmatic family. | Semantic Scholar
c-MYC: more than just a matter of life and death | Nature Reviews Cancer
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells: Cell
Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway
Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat | Signal Transduction and Targeted Therapy
Targeting oncogenic Myc as a strategy for cancer treatment | Signal Transduction and Targeted Therapy
Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer | Scientific Reports
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text
Recent Update on Targeting c-MYC G-Quadruplexes by Small Molecules for Anticancer Therapeutics | Journal of Medicinal Chemistry
Reproducibility in Cancer Biology: Small molecules remain on target for c- Myc | eLife
Transcriptional Amplification in Tumor Cells with Elevated c-Myc - ScienceDirect
Therapeutic targeting of “undruggable” MYC - eBioMedicine